What Litigation Against Pharma Company Could Mean for ‘Duty to Innovate’

Consider writing about:

Litigation filed against Gilead Sciences by users of the biopharmaceutical company’s HIV medicine; what to know about a case recently heard by the California Supreme Court; what the outcome of this csae could mean for the pharmaceutical industry specifically and, more broadly speaking, for manufacturers’ duty of care, other obligations, and liability risks regarding their existing products and their related product development options and actions.